Found 5 matching trials
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
PHASE1The study is being conducted to explore the reasonable dosage and evaluate ...
Location
Hunan Provincial Cancer Hospital
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
PHASE1This study is a phase Ib/II study to evaluate the efficacy, safety and tole...
Location
Sun Yat-Sen University Cancer Center
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC
PHASE2The study is being conducted to to explore the reasonable dosage and evalua...
Location
Shanghai Pulmonary Hospital
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
PHASE1This study is an open-label first-in-human phase I clinical study to evalua...
Status
Enrolling By Invitation
Location
Stanford University
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer
PHASE2The study is to explore the the reasonable dosage and to evaluate the effic...
Location
The Second Hospital of Anhui Medical University